NASDAQ:GNOM

Global X Genomics & Biotechnology ETF (GNOM) Price, Holdings, & News

$9.96
-0.07 (-0.70%)
(As of 02:23 PM ET)
Today's Range
$9.89
$10.06
50-Day Range
$9.68
$12.29
52-Week Range
$8.63
$13.33
Volume
43,633 shs
Average Volume
68,439 shs
Market Capitalization
$90.84 million
Assets Under Management
$91.35 million
Dividend Yield
0.00%
Net Expense Ratio
0.50%
GNOM stock logo

About Global X Genomics & Biotechnology ETF (NASDAQ:GNOM)

Complete Genomics, Inc. is a life sciences company that has developed and commercialized a deoxyribonucleic acid (DNA) sequencing platform. Its complete genomics analysis platform (CGA) Platform, combines its human genome sequencing technology with its advanced informatics and data management software and its end-to-end, outsourced service model to provide its customers with data that is ready to be used for genome-based research. Its genome sequencing center combines a high-throughput sample preparation facility, a collection of its high-throughput sequencing instruments and a large- scale data center. Its customers include some of the global academic and government research centers and biopharmaceutical companies. Effective March 18, 2013, BGI-Shenzhen announced that through its wholly-owned subsidiary, Beta Acquisition Corporation, it has completed the acquisition of the Company.

GNOM Stock Price History

GNOM ETF News Headlines

The Analyst Landscape: 4 Takes On 10x Genomics
top AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)
AI was by far the biggest tech investing trend right now. But Ross Givens says the #1 artificial intelligence stock[/lin] is NOT Microsoft, Google, Amazon or Apple. Nope — his research is pointing to a tiny, under-the-radar stock that’s trading for just a few dollars right now… And could soon shoot to the moon, handing early investors a windfall.
Global X Genomics & Biotechnology UCITS ETF (GNOG.L)
Global X Genomics & Biotechnology ETF (GNOM)
Global X S&P 500® Catholic Values ETF (CATH)
top AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)
AI was by far the biggest tech investing trend right now. But Ross Givens says the #1 artificial intelligence stock[/lin] is NOT Microsoft, Google, Amazon or Apple. Nope — his research is pointing to a tiny, under-the-radar stock that’s trading for just a few dollars right now… And could soon shoot to the moon, handing early investors a windfall.
See More Headlines
Receive GNOM Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Global X Genomics & Biotechnology ETF and its competitors with MarketBeat's FREE daily newsletter.

Fund Details

Issuer
Global X
Fund Name
Global X Genomics & Biotechnology ETF
Tax Classification
Regulated Investment Company
Current Symbol
NASDAQ:GNOM
Inception Date
4/5/2019
Fund Manager
Chang Kim, James Ong, Nam To, Wayne Xie

Fund Focus

Asset Class
Equity
Benchmark
Solactive Genomics Index
Category
Strategy
Focus
Theme
Development Level
Blended Development
Region
Global
Number of Holdings
44

Fund Statistics

Assets Under Management
$91.35 million
Average Daily Volume
$0.00
Discount/Premium
0.01%

Administrator, Advisor and Custodian

Administrator
Global X Management Company LLC
Advisor
Global X Management Company LLC
Custodian
Brown Brothers Harriman & Co.
Distributor
SEI Investments Distribution Co.
Transfer Agent
Brown Brothers Harriman & Co.
Trustee
N/A
Lead Market Maker
Susquehanna

Options

Optionable
N/A
Short Interest
11,000 shs

Miscellaneous

Beta
1.03
Creation Unit
50,000
Creation Fee
$500.00
Investing Strategies To Help Grow Your Retirement Income Cover

Need to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.

Get This Free Report

Global X Genomics & Biotechnology ETF Expenses

TypeGNOMTheme ETFsEquity ETFsNASDAQ ETFsAll ETFs
Management Fee0.50%0.57%0.54%0.48%0.51%
Other Expenses0.00%0.72%0.54%0.34%0.58%
Total Expense0.50%0.72%0.70%0.58%0.70%
Fee Waiver0.00%-0.76%-0.55%-0.22%-0.57%
Net Expense0.50%0.59%0.60%0.54%0.58%

Global X Genomics & Biotechnology ETF (GNOM) Holdings & Exposure

GNOM Sector Exposure

GNOM Industry Exposure


GNOM ETF - Frequently Asked Questions

How have GNOM shares performed in 2024?

Global X Genomics & Biotechnology ETF's stock was trading at $11.56 on January 1st, 2024. Since then, GNOM shares have decreased by 13.8% and is now trading at $9.96.
View the best growth stocks for 2024 here
.

What does GNOM invest in?

Global X Genomics & Biotechnology ETF is a equity fund issued by Global X. GNOM focuses on theme investments and follows the Solactive Genomics Index. The fund's investments total to approximately $91.35 million assets under management.

What stocks does Global X Genomics & Biotechnology ETF hold?
What is the management fee for Global X Genomics & Biotechnology ETF?

Global X Genomics & Biotechnology ETF's management fee is 0.50% and has no other recorded expenses or fee waivers. The net expense ratio for GNOM is 0.50%.

What other stocks do shareholders of Global X Genomics & Biotechnology ETF own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Global X Genomics & Biotechnology ETF investors own include Inovio Pharmaceuticals (INO), Gilead Sciences (GILD), Intel (INTC), Pfizer (PFE), Quest Diagnostics (DGX), Micron Technology (MU), Dynavax Technologies (DVAX), Matinas BioPharma (MTNB).

Who are Global X Genomics & Biotechnology ETF's major shareholders?

Global X Genomics & Biotechnology ETF's stock is owned by a variety of retail and institutional investors. Top institutional shareholders include Raymond James Financial Services Advisors Inc. (2.89%).

How do I buy shares of Global X Genomics & Biotechnology ETF?

Shares of GNOM stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:GNOM) was last updated on 4/24/2024 by MarketBeat.com Staff

From Our Partners